| Bioactivity | Brocresine (NSD-1065) is an orally active histidine decarboxylase inhibitor and inhibits the formation of histamine from histidine. Brocresine is also a L-amino acid decarboxylase inhibitor with both a peripheral and central action. Brocresine inhibits gastric secretory response to administration of exogenous gastrin[1][2]. |
| CAS | 555-65-7 |
| Formula | C7H8BrNO2 |
| Molar Mass | 218.05 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Howse PM, et al. Brocresine in Parkinson's disease. Action of a peripheral and central decarboxylase inhibitor in potentiating levodopa. J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):27-9. [2]. Fletcher TL, et al. Effect of 4-bromo-3-hydroxybenzyloxyamine (Brocresine) on gastric secretion in pouch dogs. Proc Soc Exp Biol Med. 1969 Oct;132(1):205-11. |